Quantcast

Latest Thiols Stories

2009-12-10 10:09:00

RALEIGH, N.C., Dec. 10 /PRNewswire/ -- Ajinomoto announced today a new initiative to develop propriety fermentation technology for producing cystine and cysteine, amino acids important in a wide array of applications, including pharmaceuticals, flavorings, and cosmetics. Ajinomoto's expansion in this marketplace will offer additional sourcing options for manufacturers, as it will make available cystine and cysteine that are produced by microbial fermentation of starches and/or sugars....

2009-12-07 09:00:00

NEW YORK, Dec. 7 /PRNewswire/ -- In an effort to heighten awareness and further educate the medical community about the importance of glutathione, Kyowa Hakko USA is sponsoring a special glutathione workshop entitled, Absorption of Oral Glutathione and Implications for Human Health, at the 17th Annual World Congress on Anti-Aging Medicine (A4M) in Las Vegas, Thursday, December 10, 6-8 p.m. in the South Pacific Ballroom I at the Mandalay Bay Resort and Convention Center. To RSVP for the free...

2009-12-01 11:36:00

NASHVILLE, Tenn., Dec. 1 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that an independently conducted study of Acetadote (acetylcysteine) Injection, or intravenous N-acetylcysteine, as a cost-saving treatment for acetaminophen poisoning was published in Volume 12, Number 4 of the peer-reviewed Journal of Medical Economics, distributed in December. The study concludes that Acetadote is a less costly treatment regimen than oral N-acetylcysteine in...

2009-11-23 05:30:00

NOVATO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a...

2009-11-22 07:56:26

We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Now, researchers at the University of Michigan, along with colleagues in Belgium, have discovered a new antioxidant system that protects single cysteines. The research appears in the Nov. 20 issue of the journal Science. Our body's proteins, which...

2009-11-17 10:40:03

Judging from the number of juices and teas advertised as containing antioxidants, consumers are aware of the dangers of oxidative stress. But what is the best way to measure it "“ and fight it? Doctors at Emory University School of Medicine have identified a substance in the blood that may be useful in predicting an individual's risk for heart disease. The substance is cystine, an oxidized form of the amino acid cysteine and an indirect measure of oxidative stress. In a study of more...

2009-10-27 09:00:00

NEW YORK, Oct. 27 /PRNewswire/ -- Life Extension® the global authority on nutrition, health and wellness, as well as a provider of scientific information on anti-aging supplements and therapies, has introduced Glutathione, Cysteine & C product formulated with 50 mg of Setria® Glutathione from Kyowa Hakko USA. Glutathione, Cysteine & C is available from Life Extension® in 100 count bottles at...

2009-10-12 05:30:00

NOVATO, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population. At the completion of the initial six-month...

2009-10-01 05:30:00

NOVATO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors. He is also CEO of EPISTAT, an international healthcare technology...

2009-09-30 05:30:00

NOVATO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced today the completion of their merger. The combined company is named "Raptor Pharmaceutical Corp." and will commence trading on September 30, 2009 on the NASDAQ Capital Market under the ticker symbol "RPTP." Pursuant to NASDAQ's regulations, for the first 20 trading days the ticker symbol will be...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related